Sherry Denton, NP
Adult Health · Scottsdale, AZNPI 1851726707
Payments from drug & device makers
Across 581 payments — averaging $40.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Dendreon Pharmaceuticals LLC$7K
- Johnson & Johnson$3K
- Sumitomo Pharma America, Inc.$2K
- Pfizer$2K
- Myriad Genetic Laboratories, Inc.$1K
- AbbVie$909
- plus $7K from 34 others
What the payments were for
- Consulting fees$5002%
- Speaking & faculty fees$2,53511%
- Food & beverage$20,03986%
- Education$2121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Dendreon Pharmaceuticals LLC | 138 | $7,450 |
| Johnson & Johnson | 64 | $3,003 |
| Sumitomo Pharma America, Inc. | 35 | $1,859 |
| Pfizer | 42 | $1,654 |
| Myriad Genetic Laboratories, Inc. | 38 | $1,375 |
| AbbVie | 14 | $909 |
| Bayer | 27 | $839 |
| Progenics Pharmaceuticals, Inc. | 23 | $681 |
| Myovant Sciences Inc. | 29 | $585 |
| Novartis | 16 | $541 |
| Merck | 21 | $514 |
| Janssen Scientific Affairs, LLC | 1 | $500 |
| Blue Earth Diagnostics | 24 | $464 |
| Astellas Pharma US Inc | 18 | $435 |
| Ferring Pharmaceuticals Inc. | 19 | $352 |
| Boston Scientific | 7 | $313 |
| Tolmar, Inc. | 4 | $254 |
| Calyxo, Inc. | 3 | $199 |
| Urogen Pharma, Inc. | 11 | $192 |
| Immunitybio, Inc. | 3 | $144 |
| 180 Medical, Inc. | 6 | $130 |
| AstraZeneca | 6 | $122 |
| Coloplast | 7 | $116 |
| Profound Medical Corp. | 1 | $104 |
| Amgen | 1 | $86 |
| Teleflex LLC | 3 | $75 |
| Endo Pharmaceuticals Inc. | 3 | $47 |
| Alnylam Pharmaceuticals Inc. | 2 | $47 |
| Laborie Medical Technologies Corp. | 3 | $43 |
| Vertex | 2 | $40 |
| Telix Pharmaceuticals | 1 | $34 |
| Sun Pharmaceutical Industries Inc. | 1 | $32 |
| Bioprotect Medical, Inc. | 1 | $23 |
| Procept Biorobotics Corporation | 1 | $21 |
| Tempus AI, Inc | 1 | $21 |
| Endo USA, Inc. | 1 | $20 |
| Inspire Medical Systems, Inc. | 1 | $19 |
| BD | 1 | $17 |
| Urovant Sciences Inc | 1 | $14 |
| Accord Healthcare, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$23,285 in reported general payments places this provider in the 95th percentile of 314 adult health providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XtandiEnzalutamide | 238 | $3,351,453 |
| ErleadaApalutamide | 140 | $2,014,625 |
| OrgovyxRelugolix | 486 | $1,278,140 |
| NubeqaDarolutamide | 54 | $691,335 |
| Abiraterone Acetate | 15 | $44,193 |
| Megestrol Acetate | 24 | $597 |
| Tamsulosin Hcl | 31 | $432 |
| Prednisone | 30 | $187 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncXtandi | $435 | $3,351,453238 claims |
| Johnson & JohnsonErleada | $3,003 | $2,014,625140 claims |
| Sumitomo Pharma America, Inc.Orgovyx | $1,859 | $1,278,140486 claims |
| BayerNubeqa | $839 | $691,33554 claims |
| Janssen Scientific Affairs, LLCAbiraterone Acetate | $500 | $44,19315 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 314 adult health providers in Arizona.
Other adult health in Scottsdale
- Heather McCoyScottsdale$156K
- Leslie WojtowiczScottsdale$12K
- Melissa PrinceScottsdale$6K
- Joanne SchlesingerScottsdale$5K
- Lisa WilliamsScottsdale$3K
- Jennifer CollinsScottsdale$2K
- Ashleigh OrtegaScottsdale$2K
- Therese SargentPhoenix$442K
- Jennifer MylodGlendale$131K
- Natalie WilsonPhoenix$94K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.